1. Home
  2. VTEX vs AVBP Comparison

VTEX vs AVBP Comparison

Compare VTEX & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTEX
  • AVBP
  • Stock Information
  • Founded
  • VTEX 1999
  • AVBP 2021
  • Country
  • VTEX United Kingdom
  • AVBP United States
  • Employees
  • VTEX N/A
  • AVBP N/A
  • Industry
  • VTEX Computer Software: Prepackaged Software
  • AVBP
  • Sector
  • VTEX Technology
  • AVBP
  • Exchange
  • VTEX Nasdaq
  • AVBP NYSE
  • Market Cap
  • VTEX 1.1B
  • AVBP 925.7M
  • IPO Year
  • VTEX 2021
  • AVBP 2024
  • Fundamental
  • Price
  • VTEX $6.01
  • AVBP $24.41
  • Analyst Decision
  • VTEX Strong Buy
  • AVBP Strong Buy
  • Analyst Count
  • VTEX 5
  • AVBP 5
  • Target Price
  • VTEX $10.20
  • AVBP $36.80
  • AVG Volume (30 Days)
  • VTEX 700.5K
  • AVBP 157.5K
  • Earning Date
  • VTEX 02-25-2025
  • AVBP 02-02-2025
  • Dividend Yield
  • VTEX N/A
  • AVBP N/A
  • EPS Growth
  • VTEX N/A
  • AVBP N/A
  • EPS
  • VTEX 0.05
  • AVBP N/A
  • Revenue
  • VTEX $225,906,000.00
  • AVBP N/A
  • Revenue This Year
  • VTEX $17.08
  • AVBP N/A
  • Revenue Next Year
  • VTEX $18.48
  • AVBP N/A
  • P/E Ratio
  • VTEX $126.79
  • AVBP N/A
  • Revenue Growth
  • VTEX 21.27
  • AVBP N/A
  • 52 Week Low
  • VTEX $5.60
  • AVBP $14.35
  • 52 Week High
  • VTEX $9.59
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • VTEX 49.07
  • AVBP 36.68
  • Support Level
  • VTEX $5.97
  • AVBP $23.63
  • Resistance Level
  • VTEX $6.19
  • AVBP $26.54
  • Average True Range (ATR)
  • VTEX 0.17
  • AVBP 1.47
  • MACD
  • VTEX 0.04
  • AVBP -0.17
  • Stochastic Oscillator
  • VTEX 68.64
  • AVBP 16.00

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: